What is the market advantage of shengnuo biotechnology, a leading manufacturer of peptide drugs?

  • Chengdu Shengnuo Biotechnology Co., Ltd. (hereinafter referred to as “shengnuo biotechnology”) is a high-tech enterprise with advanced and efficient peptide drug technology research and development and large-scale production capacity.
  • Although the R & D process of peptide drugs is similar to that of traditional small molecular drugs, there are unique differences in process design, preparation methods, structure confirmation, quality research, R & D and production equipment.
  • Among them, the R & D and production capacity of polypeptide drugs are the main competitive advantages and business development foundation of shengnuo biotechnology.

Chengdu Shengnuo Biotechnology Co., Ltd. (hereinafter referred to as “shengnuo biotechnology”) is a high-tech enterprise with advanced and efficient peptide drug technology research and development and large-scale production capacity.

The main business of shengnuo biotechnology is independent research and development, production and sales of peptide raw materials and preparation products with large market capacity and strong competitiveness at home and abroad.

Meanwhile, relying on its technical advantages in the field of peptide drug research and development and large-scale production, shengnuo biotechnology provides peptide innovative pharmaceutical pharmaceutical research services, peptide product customization production services and peptide drugs for domestic and foreign pharmaceutical enterprises Product technology transfer services.

Although the R & D process of peptide drugs is similar to that of traditional small molecular drugs, there are unique differences in process design, preparation methods, structure confirmation, quality research, R & D and production equipment.

Especially, it is difficult to scale up the production capacity of several kilogram level from laboratory preparation to commercialization stage. Therefore, large-scale production becomes the key to commercialization of peptide drugs. shengnuo biotechnology uses chemical synthesis method to develop and produce peptide drugs.

Its main business relies on the large-scale research and development and production capacity of polypeptide based on peptide synthesis and modification technology. Its products and services cover the complete life cycle of peptide drugs from drug screening stage, preclinical research stage, clinical research stage to commercialization stage.

As one of the early established professional polypeptide drug manufacturers in China, shengnuo biotechnology has become one of the few enterprises in the field of polypeptide drugs with the whole industrial chain layout of R & D, production and sales of polypeptide raw materials and preparations after years of experience accumulation and industrial development.

It is one of the most powerful peptide drug synthesis and production technology platforms in China 1、 At the same time, it is also one of the competitors in the global standard market polypeptide generic drug industry chain.

Among them, the R & D and production capacity of polypeptide drugs are the main competitive advantages and business development foundation of shengnuo biotechnology.

The company has selected polypeptide generic drugs with large market capacity and strong market competitiveness at home and abroad for research and development, and has mastered the large-scale production technology of 15 polypeptide varieties.

As of 2019, shengnuo ranked the 7th in the world in terms of the number of active peptides registered by FDA in the world, and it was still the 7th in the domestic market in terms of the number of active products registered in the United States, and the number of active products of shengnuo was still the 7th in China Eleven kinds of polypeptide preparations have been approved in China, ranking among the top three in terms of quantity.

In the field of high difficulty peptide synthesis, shengnuo biotechnology has realized the large-scale production technology of long peptide chain peptide raw materials composed of more than 30 amino acids, such as enfluptide, liraglutide, tripatide, exenatide, etc., which breaks through the technical problems of high impurity quality caused by multiple disulfide bonds and cyclic peptides in the variety structure of zikonotide and linalopeptide.

The R & D capability and large-scale production capacity of shengnuo biotechnology for high-difficulty peptide drugs enable the company to provide bulk drug support for many multinational generic pharmaceutical enterprises in the international standardized market, and to launch the first generic product in the domestic market, so as to seize the new market and avoid vicious competition.

For sale, buy peptides, purchase peptides, and buy peptides online, you can find the Chinese peptide company:
Shengnuo Biotechnology is a high-tech China polypeptide manufacturers,who has over 19 years experience for the biotechnology .Our Products involve peptide raw materials,polypeptide drug.
Our 0 defect has passed the FDA certification, and has become the first-class professional polypeptide drug and product development and large-scale production and export industry in China .
Our service scope:peptide synthesis、peptide hormones、peptide medicine、beauty peptide、peptide medicine product、peptide technology transfer、peptide technology service、peptide large-scale production、export of peptide
Thymopentin for Injection、 Thymalfasin for Injection 、 Bivalirudin 、Bulk Drug、 Liraglutide ……